Coronary interventions

Hybrid strategy with a bioresorbable scaffold and a drug-coated balloon for diffuse coronary artery disease: the “no more metallic cages” multicentre pilot experience

EuroIntervention 2016;11:e1589-e1595 published online e-edition April 2016. DOI: 10.4244/EIJV11I14A309

Alfonso Ielasi
Alfonso Ielasi1, MD; Tadashi Miyazaki2,3, MD; Salvatore Geraci4, MD; Luca Testa5, MD, PhD; Mohamed Abdel-Wahab6, MD, PhD; Hiroyoshi Kawamoto2,3, MD; Neil Ruparelia2,3, MD; Takao Sato6, MD; Giuseppe Caramanno4, MD; Francesco Bedogni5, MD; Maurizio Tespili1, MD; Antonio Colombo2,3, MD; Azeem Latib2,3*, MD
1. Cardiology Division, Bolognini Hospital, Seriate (BG), Italy; 2. Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy; 3. Interventional Cardiology Unit, EMO-GVM Centro Cuore Columbus, Milan, Italy; 4. Cardiology Division, Sa

Aims: Our aim was to assess the feasibility and results of a hybrid approach with a bioresorbable scaffold (BRS) plus a drug-coated balloon (DCB) for the treatment of diffuse coronary art

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

angioplastybioresorbable scaffolddiffuse coronary artery diseasedrug-coated balloonoutcomes
Coronary interventionsStents and scaffoldsTools, devices and techniques
Read next article
The collateral circulation of coronary chronic total occlusions

Latest news